This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
SDX
0.00%
6.2¢
SIENNA CANCER DIAGNOSTICS LIMITED
Currently unlisted.
Proposed listing date: 3 AUGUST 2017 11:00AM AEST
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SDX | News: SDX Sienna Cancer Diagnostics Appoints Inside Diagnósticos As Exclusive Distribution Partner... | 18/03/19 | 0 | 198 | |||
|
|||||||
SDX | Ann: Sienna Appoints Exclusive Distribution Partner for Brazil | 18/03/19 | 0 | 242 | |||
|
|||||||
SDX | Ann: CEO Interview - March 2019 | 13/03/19 | 0 | 153 | |||
|
|||||||
SDX | Ann: Furthers Global Expansion with Distributor for Singapore | 23/02/19 | 4 | 901 | |||
|
|||||||
SDX | News: SDX Sienna Cancer Diagnostics Appoints Mediwell Enterprise As Distribution Partner For... | 04/02/19 | 0 | 66 | |||
|
|||||||
SDX | Ann: Appendix 4D and Half-year financial report | 31/01/19 | 0 | 97 | |||
|
|||||||
SDX | Ann: Appendix 4C - quarterly | 31/01/19 | 0 | 83 | |||
|
|||||||
SDX | News: SDX Sienna Cancer Diagnostics Signs Deal With Mirax Corporation | 23/01/19 | 1 | 284 | |||
|
See All Discussions